首页> 外文期刊>American Journal of Veterinary Research >Evaluation of the effects of a commercially available Salmonella Newport siderophore receptor and porin protein vaccine on fecal shedding of Salmonella bacteria and health and performance of feedlot cattle
【24h】

Evaluation of the effects of a commercially available Salmonella Newport siderophore receptor and porin protein vaccine on fecal shedding of Salmonella bacteria and health and performance of feedlot cattle

机译:评估市售沙门氏菌纽波特铁载体受体和孔蛋白疫苗对沙门氏菌粪便脱落,养牛场和养牛场性能的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Objective To evaluate effects of a Salmonella Newport siderophore receptor and porin protein (SRP) vaccine on cattle health and performance and on prevalence of fecal shedding of Salmonella bacteria in feedlot cattle.Animals-1,591 beef cattle.Procedures-Cattle were randomly allocated within a replicate (n = 10 replicates [20 total pens]), administered 2 mL of a Salmonella Newport SAP vaccine (n = 795 cattle) or a placebo (796), and revaccinated approximately 21 days after the first administration. Health and performance data were recorded by trained feedlot personnel who were blinded to treatment. Fresh fecal samples (n = 25) were collected from pen floors on days 0, 60, and 120 and within 24 hours of cattle harvest and were subjected to selective Salmonella culture and serotyping by laboratory personnel who were blinded to treatment. Pen-level mixed models were used to analyze data.Results-Significant differences in fecal prevalence of Salmonella bacteria or health and performance variables were not detected between vaccinated and control cattle. Salmonella bacteria were recovered from all 10 replicates, and cumulative prevalence estimates ranged from 1.5% to 22%. Overall prevalence of fecal shedding of Salmonella bacteria was 10.2% and 10.9% in vaccinated and control cattle, respectively. Overall morbidity risk was 34.8% for both vaccinated and control cattle. Overall mortality risks were 1.9% and 1.1% for vaccinated and control cattle, respectively.Conclusions and Clinical Relevance-In this setting, administration of the Salmonella Newport SAP vaccine in feedlot cattle had no effect on fecal prevalence of Salmonella bacteria or cattle health and performance. (Am J Vet Res 2011;72:239-247)
机译:目的评估沙门氏菌纽波特铁载体受体和孔蛋白(SRP)疫苗对肉牛健康和生产性能以及沙门氏菌粪便脱落率的影响。动物1,591头牛(n = 10重复[共20支]),注射2 mL沙门氏菌Newport SAP疫苗(n = 795牛)或安慰剂(796),并在第一次给药后约21天进行疫苗接种。健康和性能数据是由训练有素的育肥场人员记录的,他们对治疗不知情。在牛收获后第0、60和120天以及收获后24小时之内从笔舍采集新鲜的粪便样本(n = 25),并由不愿接受治疗的实验室人员进行选择性沙门氏菌培养和血清分型。结果:在接种牛和对照牛之间未检出沙门氏菌的粪便流行率或健康和性能变量的显着差异。从所有10个重复样本中回收沙门氏菌,累积流行率估计为1.5%至22%。在接种牛和对照牛中,沙门氏菌的粪便脱落总体患病率分别为10.2%和10.9%。接种牛和对照牛的总体发病风险均为34.8%。接种牛和对照牛的总死亡风险分别为1.9%和1.1%。结论和临床意义-在这种情况下,在育肥牛中施用沙门氏菌Newport SAP疫苗对粪便中沙门氏菌的流行率或牛的健康和性能无影响。 。 (Am J Vet Res 2011; 72:239-247)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号